A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone — Stella
A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(52 sites)
United States
Norton Cancer Institute, Downtown, Louisville, Kentucky
M Health Fairview Clinics and Surgery Center - Minneapolis, Minneapolis, Minnesota
The Ohio State University Wexner Medical Center, Columbus, Ohio
Australia
Gosford Hospital, Gosford, New South Wales
Andrew Love Cancer Centre, Geelong, Victoria
Brazil
Hospital de Amor, Barretos
Liga Norte Riograndense contra o cancer, Natal
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto